Valuation: Kamada Ltd.

Market Cap 125.35Cr 0 41Cr 36Cr 33Cr 31Cr 57Cr 3.95TCr 58Cr 398.09Cr 155.27Cr 1.92TCr 152.96Cr 149.66Cr 6.68TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 125.35Cr 0 41Cr 36Cr 33Cr 31Cr 57Cr 3.95TCr 58Cr 398.09Cr 155.27Cr 1.92TCr 152.96Cr 149.66Cr 6.68TCr EV / Sales 2026 *
2.09x
EV / Sales 2027 * 1.92x
Free-Float
54.51%
Yield 2026 *
-
Yield 2027 * -
1 day-1.27%
1 week+3.53%
Current month-0.59%
1 month+2.50%
3 months-12.02%
6 months-13.87%
Current year-3.85%
1 week 2,122
Extreme 2122
2,260
1 month 2,076
Extreme 2076
2,297
Current year 2,076
Extreme 2076
2,890
1 year 1,956
Extreme 1956
2,890
3 years 1,685
Extreme 1685
3,045
5 years 1,309
Extreme 1309
3,045
10 years 1,309
Extreme 1309
4,500
Manager TitleAgeSince
Chief Executive Officer 57 01/07/2015
Director of Finance/CFO 55 31/12/2017
Chief Operating Officer 53 01/11/2016
Director TitleAgeSince
Director/Board Member 75 13/12/1990
Chairman 77 07/03/2013
Chairman 55 12/08/2020
Date Insider Type Main position Quantity % Market Cap.
07/04/26 Free

Director

1,13,000 0.1959%
07/04/26 Free

Director

60,000 0.1040%
07/04/26 Free

Executive/Senior Manager

30,000 0.0520%
Change 5-day change 1-year change 3-year change Capi.($)
-1.27%+3.53%-16.93%+15.52% 41Cr
+0.11%-3.98%+13.89%-11.26% 6.63TCr
-0.12%+2.23%+36.63%+196.27% 5.26TCr
+0.51%+37.90%+37.90%+37.90% 4.33TCr
-1.70%-7.65%-57.75%-57.23% 3.86TCr
+1.46%-3.97%+53.17%-27.51% 2.96TCr
+0.78%+0.03%+65.07%+81.90% 2.33TCr
-1.81%-9.71%+64.46%-54.90% 2.26TCr
-1.48%+0.90%+1.76%+170.33% 2.02TCr
-1.04%-1.59%+66.57%+119.96% 1.63TCr
Average -0.44%-2.50%+26.48%+47.10% 3.13TCr
Weighted average by Cap. -0.21%-2.59%+25.28%+45.52%

Financials

2026 *2027 *
Net sales 60Cr 0 20Cr 17Cr 16Cr 15Cr 27Cr 1.89TCr 28Cr 190.63Cr 74Cr 921.61Cr 73Cr 72Cr 3.2TCr 65Cr 0 21Cr 19Cr 17Cr 16Cr 30Cr 2.06TCr 31Cr 207.87Cr 81Cr 1TCr 80Cr 78Cr 3.49TCr
Net income 7.39Cr 0 2.4Cr 2.11Cr 1.96Cr 1.8Cr 3.38Cr 232.59Cr 3.45Cr 23Cr 9.15Cr 113.45Cr 9.02Cr 8.82Cr 393.59Cr 11Cr 0 3.43Cr 3.01Cr 2.8Cr 2.58Cr 4.83Cr 331.86Cr 4.92Cr 33Cr 13Cr 161.87Cr 13Cr 13Cr 561.57Cr
Net Debt - -
Logo Kamada Ltd.
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Employees
462
Date Price Change Volume
22/26/22 ILA 2,173.00 -1.27% 78,689
21/26/21 ILA 2,201.00 +0.46% 43,808
20/26/20 ILA 2,191.00 +2.77% 4,22,843
17/26/17 ILA 2,132.00 +1.57% 12,214
16/26/16 ILA 2,099.00 -2.42% 2,59,895
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KMDA Stock